•Journal•ISSN: 1560-4071
Russian Journal of Cardiology
Russian Society of Cardiology
About: Russian Journal of Cardiology is an academic journal published by Russian Society of Cardiology. The journal publishes majorly in the area(s): Medicine & Internal medicine. It has an ISSN identifier of 1560-4071. It is also open access. Over the lifetime, 1245 publications have been published receiving 4392 citations. The journal is also known as: Russian journal of cardiology.
Papers
More filters
225 citations
212 citations
Leipzig University1, Leiden University Medical Center2, Uppsala University3, University of Modena and Reggio Emilia4, University of Barcelona5, Carol Davila University of Medicine and Pharmacy6, National and Kapodistrian University of Athens7, François Rabelais University8, Royal Melbourne Hospital9, University of Liverpool10, University of Lisbon11, University of Birmingham12, University of Groningen13, University of Central Lancashire14
137 citations
TL;DR: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Abstract: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
128 citations
TL;DR: In 16 years, prevalence of chronic heart failure (CHF) in Russia increased from 4,9% (1998) to 10,2% (2014), p=0,01; however, number of CHF patients with III-IV FC NYHA increased more dramatically: from 1,2%.
Abstract: The analysis is presented, of the three epidemiologic studies (EPOCHA-CHF, EPOCHA-Hospital-CHF, EPOCHA-Decompensation-CHF). In 16 years, prevalence of chronic heart failure (CHF) in Russia increased from 4,9% (1998) to 10,2% (2014), p=0,01. However, number of CHF patients with III-IV FC NYHA increased more dramatically: from 1,2% (1998) to 4,1% (2014), p=0,002. This happened due to significant increse of the age of patients selection from 64,0±11, 9 y.o. (1998) to 69,9±12,2 y.o. (2014), p=0,02; increase of the weight of etiological causes of ischemic heart disease and myocardial infarction. Overall mortality of the patients with any CHF is 6% per year. This value depends on low rate of prescription of RAAS blockers and beta-blockers during outpatient stage, with usage of low dosages of medications that does not control BP and heartrate. Patients with CHF decompensation led to hospitalization are significantly older than in general population (72,9±10,5 y.o.), and gender differences are for benefit of women, as in general population. 58,2% of hospitalized patients were admitted with noncontrolled hypertension, and in 70,5% there was heartrate higher than 80 bpm. Overall mortality of CHF patients was 25,1% (46,4% died in 1 year with the formed hypotension and 22,1% with retained level of BP). Hospital mortality was 6,8%. Mortality risks increased by repeated admittances for decompensation, absence of RAAS blockers and beta-blockers in management.
105 citations